LAVA Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

September 7, 2022

https://www.globenewswire.com/news-release/2022/09/07/2511395/0/en/LAVA-Therapeutics-to-Present-at-the-H-C-Wainwright-24th-Annual-Global-Investment-Conference.html

UTRECHT, The Netherlands and PHILADELPHIA, Sept. 07, 2022 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq:LVTX), a clinical stage immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific gamma delta T cell engagers to transform the treatment of cancer, today announced that Stephen Hurly, president and chief executive officer of LAVA Therapeutics, will present in a virtual format at the H.C. Wainwright 24th Annual Global Investment Conference being held virtually and in New York City.

Read more at globenewswire.com

Related news for (LVTX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.